Search

Treatment regret in head and neck cancer – trading function for survival

Treatment for H&N cancer can be extremely tough for patients. How do we explain the likely impact as they try to make decisions? And what happens when they regret their choice? Treatment regret is a is a form of decision...

Hunting for the zorse - hybrid learning in the wake of the COVID-19 pandemic

Emma Watts, a West Midlands ENT Registrar and Digital Fellow, gives a witty and concise recollection of ENT training during COVID, and predicts how hybrid learning may be here to stay. *A zorse is the offspring of a zebra stallion...

Cancer genetics and signalling pathways in ENT – a review and discussion of how this can be applied to rare tumours

Introduction Cancer cases continue to increase worldwide, and­­ head and neck cancer is a major global health issue, with an estimated global burden of over 630,000 new cases and over 350,000 deaths per year [1]. The term ‘head and neck...

Frederik Dikkers: championing change in laryngology

Prof Dikkers shares the details of his journey into ENT surgery, his dedication to treating laryngeal papillomatosis, and his pioneering advancements in button battery safety. Recurrent respiratory papillomatosis (RRP) is one of the most frustrating conditions managed by laryngologists. There...

Pre-clinical development of magnetic delivery of therapy to middle and inner ears

Why are we developing this technology? A key problem in drug delivery is getting the therapy to the right place in the body, which is especially challenging for targets that are small, deep and are protected or surrounded by anatomical...